AGEN Agenus
- 13.355
- +0.095+0.72%
Agenus News
Express News | Agenus Regains Compliance With Nasdaq Minimum Bid Price Requirement
PEGY, CGEM and IFBD Among Mid-day Movers
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.
Great Week for Agenus Inc. (NASDAQ:AGEN) Institutional Investors After Losing 72% Over the Previous Year
Key Insights Significantly high institutional ownership implies Agenus' stock price is sensitive to their trading actions The top 19 shareholders own 50% of the company Insiders have bought recen
Express News | Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Sector Update: Health Care Stocks Slipping Late Afternoon
Health care stocks were falling late Friday afternoon, with the NYSE Health Care Index sliding 1.6% and the Health Care Select Sector SPDR Fund (XLV) down 1.5%. The iShares Biotechnology ETF (IBB) los
Sector Update: Health Care
Health care stocks fell late Friday afternoon with the NYSE Health Care Index sliding 1.6% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.7%. The iShares Biotechnology ETF (IBB) tumbled
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
The latest Phase 1 trial results of Agenus' botensilimab and balstilimab combination therapy for metastatic CRC showcase promising clinical activity.
Agenus Shares Decline After Update on Early Stage Colorectal Cancer Drug Trial
Agenus (AGEN) shares fell 6.8% in recent Friday trading after the company reported a 23% overall response rate in 77 patients in an update to its phase 1 clinical trial of the botensilimab and balstil
Express News | Agenus Shares Are Trading Lower. The Company Announced Updated Results From Its Phase 1 Clinical Trial of BOT/BAL Combination Therapy in Patients With Metastatic CRC That Is Not Microsatellite Instability-high or Deficient Mismatch Repair
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Agenus Inc - Company Plans to Submit Phase 2 Data to a Major Medical Conference in Second Half of 2024
Express News | Agenus Inc - Company Plans to Discuss Encouraging Phase 2 Interim Results With FDA
Express News | Agenus Inc: Updated Phase 1 Data Demonstrate a 12-Month Overall Survival (Os) of 71% and 18-Month Os of 62%
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Agenus To Carry Out 1-for-20 Reverse Stock Split On April 12th, 2024
April 11th - $Agenus(AGEN.US)$ is about to implement a 1-for-20 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 12th, 2024.$Agenus(AGEN.US)$ slipped 8
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday's session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ:AGEN) declined 17% to $0.4181 on Monday.
12 Health Care Stocks Moving In Monday's Intraday Session
GainersEtao International Co (NASDAQ:ETAO) stock moved upwards by 96.6% to $4.9 during Monday's regular session. The company's market cap stands at $25.0 million. Longeveron (NASDAQ:LGVN) shares moved
Crude Oil Moves Lower; Perion Network Shares Tumble
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500
Analysis
Price Target
No Data
